Institute of Pharmacology, University of Bern, Inselspital, INO-F, CH-3010 Bern, Switzerland.
Institute of General Pharmacology and Toxicology, University Hospital Frankfurt am Main, Goethe-University, Theodor-Stern Kai 7, D-60590 Frankfurt am Main, Germany.
Int J Mol Sci. 2018 May 17;19(5):1498. doi: 10.3390/ijms19051498.
Sphingosine kinase (SK) catalyses the formation of sphingosine 1-phosphate (S1P), which acts as a key regulator of inflammatory and fibrotic reactions, mainly via S1P receptor activation. Here, we show that in the human renal proximal tubular epithelial cell line HK2, the profibrotic mediator transforming growth factor β (TGFβ) induces SK-1 mRNA and protein expression, and in parallel, it also upregulates the expression of the fibrotic markers connective tissue growth factor (CTGF) and fibronectin. Stable downregulation of SK-1 by RNAi resulted in the increased expression of CTGF, suggesting a suppressive effect of SK-1-derived intracellular S1P in the fibrotic process, which is lost when SK-1 is downregulated. In a further approach, the S1P transporter Spns2, which is known to export S1P and thereby reduces intracellular S1P levels, was stably downregulated in HK2 cells by RNAi. This treatment decreased TGFβ-induced CTGF and fibronectin expression, and it abolished the strong induction of the monocyte chemotactic protein 1 (MCP-1) by the pro-inflammatory cytokines tumor necrosis factor (TNF)α and interleukin (IL)-1β. Moreover, it enhanced the expression of aquaporin 1, which is an important water channel that is expressed in the proximal tubules, and reverted aquaporin 1 downregulation induced by IL-1β/TNFα. On the other hand, overexpression of a Spns2-GFP construct increased S1P secretion and it resulted in enhanced TGFβ-induced CTGF expression. In summary, our data demonstrate that in human renal proximal tubular epithelial cells, SK-1 downregulation accelerates an inflammatory and fibrotic reaction, whereas Spns2 downregulation has an opposite effect. We conclude that Spns2 represents a promising new target for the treatment of tubulointerstitial inflammation and fibrosis.
鞘氨醇激酶 (SK) 催化鞘氨醇 1-磷酸 (S1P) 的形成,S1P 通过激活 S1P 受体主要作为炎症和纤维化反应的关键调节剂。在这里,我们表明,在人肾近端管状上皮细胞系 HK2 中,促纤维化介质转化生长因子 β (TGFβ) 诱导 SK-1 mRNA 和蛋白表达,并且平行地,它还上调纤维化标志物结缔组织生长因子 (CTGF) 和纤维连接蛋白的表达。RNAi 稳定下调 SK-1 导致 CTGF 的表达增加,表明 SK-1 衍生的细胞内 S1P 在纤维化过程中具有抑制作用,当 SK-1 下调时,这种抑制作用丢失。在进一步的方法中,已知 S1P 转运蛋白 Spns2 通过输出 S1P 从而降低细胞内 S1P 水平,通过 RNAi 在 HK2 细胞中稳定下调。这种处理降低了 TGFβ 诱导的 CTGF 和纤维连接蛋白的表达,并消除了促炎细胞因子肿瘤坏死因子 (TNF)α 和白细胞介素 (IL)-1β 对单核细胞趋化蛋白 1 (MCP-1) 的强烈诱导。此外,它增强了水通道蛋白 1 的表达,水通道蛋白 1 是在近端小管中表达的重要水通道,并且逆转了由 IL-1β/TNFα 诱导的水通道蛋白 1 下调。另一方面,Spns2-GFP 构建体的过表达增加了 S1P 的分泌,并导致 TGFβ 诱导的 CTGF 表达增强。总之,我们的数据表明,在人肾近端管状上皮细胞中,SK-1 下调加速了炎症和纤维化反应,而 Spns2 下调则具有相反的作用。我们得出结论,Spns2 是治疗肾小管间质性炎症和纤维化的有前途的新靶点。